[PDF][PDF] Systemic sclerosis: one year in review 2023
M Di Battista, G Lepri, V Codullo, M Da Rio… - Clin. Exp …, 2023 - clinexprheumatol.org
Systemic sclerosis is a rare and chronic connective tissue disease resulting from an intricate
pathogenesis and is expressed in very heterogeneous clinical manifestations. Every year …
pathogenesis and is expressed in very heterogeneous clinical manifestations. Every year …
Feature tracking cardiac magnetic resonance imaging to assess cardiac manifestations of systemic diseases
Feature-tracking cardiac magnetic resonance (FT-CMR), with the ability to quantify
myocardial deformation, has a unique role in the evaluation of subclinical myocardial …
myocardial deformation, has a unique role in the evaluation of subclinical myocardial …
Hematopoietic cell transplantation for systemic sclerosis—a review
D Levin, MS Osman, C Durand, H Kim, I Hemmati… - Cells, 2022 - mdpi.com
Systemic sclerosis (SSc) is an autoimmune, multi-organ, connective tissue disease
associated with significant morbidity and mortality. Conventional immunosuppressive …
associated with significant morbidity and mortality. Conventional immunosuppressive …
Speckle-tracking global longitudinal strain predicts death and cardiovascular events in patients with systemic sclerosis
G Stronati, F Guerra, D Benfaremo… - … Heart Journal Open, 2024 - academic.oup.com
Aims Albeit often asymptomatic, heart involvement in systemic sclerosis (SSc) represents a
negative prognostic factor, accounting for nearly one-fourth of all deaths. Global longitudinal …
negative prognostic factor, accounting for nearly one-fourth of all deaths. Global longitudinal …
Can we define difficult-to-treat systemic sclerosis?
ABSTRACT Introduction Systemic sclerosis (SSc) is a chronic autoimmune rheumatic
disease characterized by microvascular alterations, immunopathology and widespread …
disease characterized by microvascular alterations, immunopathology and widespread …
The primary cardiomyopathy of systemic sclerosis on cardiovascular magnetic resonance imaging
S Chhikara, A Kanda, FM Ogugua… - European Heart …, 2023 - academic.oup.com
Aims Cardiac disease in systemic sclerosis (SSc) may be primary or secondary to other
disease manifestations of SSc. The prevalence of the primary cardiomyopathy of SSc is …
disease manifestations of SSc. The prevalence of the primary cardiomyopathy of SSc is …
Diffusing capacity of lungs for carbon monoxide associated with subclinical myocardial impairment in systemic sclerosis: A cardiac MR study
H He, X Tong, Z Ning, J Zhou, C Du, Y Wang… - RMD open, 2023 - rmdopen.bmj.com
Background Systemic sclerosis (SSc) is characterised by microvascular and fibrotic lesions,
which are located not only in skin but also in lungs and heart. Objective This study aimed to …
which are located not only in skin but also in lungs and heart. Objective This study aimed to …
[PDF][PDF] Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients
G De Luca, C Campochiaro, G Peretto… - Clinical and …, 2023 - clinexprheumatol.org
Sirs, Early diagnosis of systemic sclerosis (SSc) is crucial for a prompt identification of organ
involvement and for an early treatment (1). The preliminary criteria for the very early …
involvement and for an early treatment (1). The preliminary criteria for the very early …
Combined peripheral and central ultrasound for the diagnosis of PAH‐SSc patients
M Correale, C Rotondo, EML Bevere… - …, 2024 - Wiley Online Library
Abstract Background Systemic Sclerosis (SSc), an intricate autoimmune disease causing
tissue fibrosis, introduces cardiovascular complexities, notably pulmonary hypertension …
tissue fibrosis, introduces cardiovascular complexities, notably pulmonary hypertension …